143 related articles for article (PubMed ID: 36325323)
1. Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection.
Yeung ST; Premeaux TA; Du L; Niki T; Pillai SK; Khanna KM; Ndhlovu LC
Front Immunol; 2022; 13():1011185. PubMed ID: 36325323
[TBL] [Abstract][Full Text] [Related]
2. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
3. Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells.
Du L; Bouzidi MS; Gala A; Deiter F; Billaud JN; Yeung ST; Dabral P; Jin J; Simmons G; Dossani ZY; Niki T; Ndhlovu LC; Greenland JR; Pillai SK
J Mol Cell Biol; 2023 Aug; 15(4):. PubMed ID: 37127426
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
5. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
6. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
7. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
8. A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal-fetal interface.
Zhao F; Tallarek AC; Wang Y; Xie Y; Diemert A; Lu-Culligan A; Vijayakumar P; Kittmann E; Urbschat C; Bayo J; Arck PC; Farhadian SF; Dveksler GS; Garcia MG; Blois SM
Front Immunol; 2023; 14():1196395. PubMed ID: 37475853
[TBL] [Abstract][Full Text] [Related]
9. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
[TBL] [Abstract][Full Text] [Related]
10. Human Galectin-9 Potently Enhances SARS-CoV-2 Replication and Inflammation in Airway Epithelial Cells.
Du L; Bouzidi MS; Gala A; Deiter F; Billaud JN; Yeung ST; Dabral P; Jin J; Simmons G; Dossani Z; Niki T; Ndhlovu LC; Greenland JR; Pillai SK
bioRxiv; 2022 May; ():. PubMed ID: 35378763
[TBL] [Abstract][Full Text] [Related]
11. Animal Models of COVID-19: Transgenic Mouse Model.
Park JG; Pino PA; Akhter A; Alvarez X; Torrelles JB; Martinez-Sobrido L
Methods Mol Biol; 2022; 2452():259-289. PubMed ID: 35554912
[TBL] [Abstract][Full Text] [Related]
12. Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy.
Lennol MP; García-Ayllón MS; Esteban M; García-Arriaza J; Sáez-Valero J
Front Immunol; 2022; 13():1001951. PubMed ID: 36311758
[TBL] [Abstract][Full Text] [Related]
13. Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice.
Kim JA; Kim SH; Seo JS; Noh H; Jeong H; Kim J; Jeon D; Kim JJ; On D; Yoon S; Lee SG; Lee YW; Jang HJ; Park IH; Oh J; Seok SH; Lee YJ; Hong SM; An SH; Bae JY; Choi JA; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Yun JW; Shin JS; Lee HY; Seo JY; Nam KT; Gee HY; Seong JK
Mol Cells; 2022 Dec; 45(12):896-910. PubMed ID: 36324270
[TBL] [Abstract][Full Text] [Related]
14. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast-mediated bone loss observed in a COVID-19 mouse model.
Awosanya OD; Dalloul CE; Blosser RJ; Dadwal UC; Carozza M; Boschen K; Klemsz MJ; Johnston NA; Bruzzaniti A; Robinson CM; Srour EF; Kacena MA
Bone; 2022 Jan; 154():116227. PubMed ID: 34607050
[TBL] [Abstract][Full Text] [Related]
16. Plasma ACE2 species are differentially altered in COVID-19 patients.
García-Ayllón MS; Moreno-Pérez O; García-Arriaza J; Ramos-Rincón JM; Cortés-Gómez MÁ; Brinkmalm G; Andrés M; León-Ramírez JM; Boix V; Gil J; Zetterberg H; Esteban M; Merino E; Sáez-Valero J
FASEB J; 2021 Aug; 35(8):e21745. PubMed ID: 34191346
[TBL] [Abstract][Full Text] [Related]
17. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.
Golden JW; Cline CR; Zeng X; Garrison AR; Carey BD; Mucker EM; White LE; Shamblin JD; Brocato RL; Liu J; Babka AM; Rauch HB; Smith JM; Hollidge BS; Fitzpatrick C; Badger CV; Hooper JW
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841215
[TBL] [Abstract][Full Text] [Related]
18. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
[TBL] [Abstract][Full Text] [Related]
19. The severity of SARS-CoV-2 infection in K18-hACE2 mice is attenuated by a novel steroid-derivative in a gender-specific manner.
Gupte SA; Bakshi CS; Blackham E; Duhamel GE; Jordan A; Salgame P; D'silva M; Khan MY; Nadler J; Gupte R
Br J Pharmacol; 2023 Oct; 180(20):2677-2693. PubMed ID: 37259182
[TBL] [Abstract][Full Text] [Related]
20. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
